A decade-long practice involving insulin prescriptions has led CVS Pharmacy to agree to pay $36.5 million to resolve allegations that it improperly billed Medicaid programs across the United States for more insulin than patients were prescribed.
For nearly six years, subscribers of Portugal's largest pay-TV providers who wanted to watch recorded television content encountered the same reality. Advertising appeared in those recordings regardless of which major operator they used. According to Portugal's Competition Authority, that was not a coincidence.
Pasadena-based Western Asset Management has agreed to pay a $100 million civil penalty to settle Securities and Exchange Commission charges that it failed to detect and prevent an alleged cherry-picking scheme carried out by its former co-chief investment officer.
A £40 million fine would have disappeared into the Treasury. Instead, £44.7 million will stay in Wales. That was the calculation behind Ofwat's decision Friday to accept a legally enforceable package of undertakings from Dŵr Cymru Welsh Water following an investigation that found serious failures in the operation of the company's wastewater network.
According to Hungary's Competition Authority (GVH), wholesalers selling beverages distributed by Maspex Olympos. were told that if they offered products below the company's recommended minimum prices, they should not advertise the actual discounted price. Instead, they were encouraged to use attention-grabbing labels such as "TOP PRICE" or "BOMB PRICE."
Beneficial ownership is one of the most established concepts in anti-money laundering compliance. It is also one of the most persistently misunderstood in practice. At onboarding, most financial institutions collect beneficial ownership declarations, identify individuals with controlling interests, and document ownership percentages as part of standard due diligence. On the surface, this appears to satisfy regulatory expectations.
Federal prosecutors announced that Matrix Medical Network, HealthFair, and HealthFair founder Shahriah “James” Ekbatani have agreed to pay a combined $56.5 million to resolve allegations that unsupported and invalid diagnoses were used to increase payments from the Medicare Advantage program. Matrix will pay $36.5 million, while HealthFair and Ekbatani agreed to pay $5 million and $15 million respectively.